
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Immune-based therapies similar to immune checkpoint inhibitors have revolutionized the systemic therapy of varied most cancers sorts. The therapeutic software of monoclonal antibodies focusing on inhibitory pathways similar to programmed cell death-1(PD-1)/programmed cell loss of life ligand 1 (PD-L1) and CTLA-Four to cells of the adaptive immune system has just lately been proven to generate significant enchancment within the medical final result of hepatocellular carcinoma (HCC).
However, present immunotherapeutic approaches induce sturdy responses in solely a subset of HCC sufferers. Since immunologic mechanisms similar to continual irritation on account of continual viral hepatitis or alcoholic and nonalcoholic fatty liver illness play an important position within the initiation, growth, and development of HCC, you will need to perceive the underlying mechanisms shaping the distinctive tumor microenvironment of liver most cancers.
The liver is an immunologic organ with massive populations of innate and innate-like immune cells and is uncovered to bacterial, viral, and fungal antigens by way of the gut-liver axis. Right here, we summarize and spotlight the position of those cells in liver most cancers and suggest methods to therapeutically goal them.
We additionally focus on present immunotherapeutic methods in HCC and description latest advances in our understanding of how the therapeutic potential of those brokers could be enhanced.
Peripheral blood T lymphocytosis in thymoma: an perception into immunobiology
Objective: Peripheral blood T lymphocytosis (PBTL) is a uncommon, but poorly understood manifestations of thymoma, which is postulated to be linked with autoimmune/paraneoplastic manifestations similar to myasthenia gravis (MG), pure crimson cell aplasia (PRCA), and so on.; extra generally encountered on this neoplasm.
Technique: We intention to explain the flowcytometric immunophenotypic information of PBTL in a 43-year-old male; 6 months after profitable completion of chemoradiotherapy (CT/RT) for a big, invasive, and metastatic kind B1 thymoma; and current a complete assessment of all such circumstances reported over final 42 years (N = 21) (1977-2019).
Consequence: A bigger dimension of the tumors (≥ 10 cm), presence of native invasion and/or distant metastasis, and sort B (cortical or lymphocyte wealthy) histology have been extra prone to be related to PBTL.
Tumors related to MG/PRCA (N = 9/21) are likely to have decrease PBTL in comparison with these with out such manifestations; and PBTL subsided following thymectomy with or with out CT/RT. Immunophenotypic evaluation of PB revealed a CD8 + > CD4 + mature (naïve) polyclonal T cells resembling late cortical thymocytes.
Conclusion: Thymic intratumoral microenvironment may affect incidence PBTL which will have a pathophysiologic hyperlink to the growth of autoimmune manifestations. Immunophenotypic traits of peripheral blood lymphoid cells ought to be the clue for correct characterization and to keep away from a misdiagnosis of a lymphoproliferative neoplasm.
Immunobiology of Acquired Resistance to Ticks
Ticks are blood-sucking arthropods of nice significance within the medical and veterinary fields worldwide. They’re thought of second solely to mosquitos as vectors of pathogenic microorganisms that may trigger severe infectious issues, such as Lyme borreliosis and tick-borne encephalitis.
Exhausting (Ixodid) ticks feed on host animals for a number of days and inject saliva along with pathogens to hosts throughout blood feeding. Some animal species can purchase resistance to blood-feeding by ticks after a single or repeated tick infestation, leading to decreased weights and numbers of engorged ticks or the loss of life of ticks in subsequent infestations. Importantly, this acquired tick resistance (ATR) can cut back the danger of pathogen transmission from pathogen-infected ticks to hosts.
That is the premise for the event of tick antigen-targeted vaccines to forestall tick infestation and tick-borne ailments. Accumulation of basophils is detected within the tick re-infested pores and skin lesion of animals exhibiting ATR, and the ablation of basophils abolishes ATR in mice and guinea pigs, illustrating the crucial position for basophils within the expression of ATR.
On this assessment article, we offer a complete overview of latest advances in our understanding of the mobile and molecular mechanisms accountable for the event and manifestation of ATR, with a selected deal with the position of basophils.

T-cell immunobiology and cytokine storm of COVID-19
2019 coronavirus illness (COVID-19) presents as a newly acknowledged pneumonia and will quickly progress into acute respiratory misery syndrome which has caused a world pandemic. Till now, no healing remedy has been strongly beneficial for COVID-19 aside from customized supportive care.
T cells and virus-specific T cells are important to guard in opposition to virus an infection, together with COVID-19. Delayed immune reconstitution (IR) and cytokine storm (CS) stay severe obstacles for the remedy of COVID-19.
Most COVID-19 sufferers, particularly amongst aged sufferers, had marked lymphopenia and elevated neutrophils, however T cell counts in extreme COVID-19 sufferers surviving the illness steadily restored later.
Elevated pro-inflammatory cytokines, significantly IL-6, IL-10, IL-2, and IL-17, and exhausted T cells are present in peripheral blood and the lungs. It means that Thymosin α1 and adoptive COVID-19-specific T cells might enhance IR whereas convalescent plasma, IL-6 blockade, mesenchymal stem cells, and corticosteroids might suppress CS.
Extra medical research on this discipline worldwide are urgently warranted to pave the best way for remedy of COVID-19 sooner or later.
In response to a necessity for a normal catalog of genome variation to deal with the large-scale sampling designs required by affiliation research, gene mapping and evolutionary biology, the Nationwide Middle for Biotechnology Data (NCBI) has established the dbSNP database [S.T.Sherry, M.Ward and K. Sirotkin (1999) Genome Res., 9, 677-679]. Submissions to dbSNP will probably be built-in with different sources of knowledge at NCBI similar to GenBank, PubMed, LocusLink and the Human Genome Venture information. The entire contents of dbSNP can be found to the general public at
Fluorescent proteins are genetically encoded, simply imaged reporters essential in biology and biotechnology. When a protein is tagged by fusion to a fluorescent protein, interactions between fluorescent proteins can undesirably disturb focusing on or operate. Sadly, all wild-type yellow-to-red fluorescent proteins reported to this point are obligately tetrameric and sometimes poisonous or disruptive.
The primary true monomer was mRFP1, derived from the Discosoma sp. fluorescent protein “DsRed” by directed evolution first to extend the pace of maturation, then to interrupt every subunit interface whereas restoring fluorescence, which cumulatively required 33 substitutions.
Though mRFP1 has already confirmed extensively helpful, a number of properties might bear enchancment and extra colours can be welcome. We report the following technology of monomers. The most recent crimson model matures extra utterly, is extra tolerant of N-terminal fusions and is over tenfold extra photostable than mRFP1. Three monomers with distinguishable hues from yellow-orange to red-orange have greater quantum efficiencies.
![]() PI |
|||
PI | ImmunoStep | 400 test | EUR 184.8 |
![]() PI/RNAse |
|||
PI/RNASE | ImmunoStep | 200 test | EUR 208.2 |
![]() 50 ML AMPHOTERICIN B, LIQUID 250 µG/ML SOLUBILIZED |
|||
30-003-CF | CORNING | 50 mL/pk | EUR 97.2 |
Description: Media Catalog; Cell Culture Reagents |
![]() 50 ML KANAMYCIN SULFATE, LIQUID, 5,000 µG/ML SOLUTION |
|||
30-006-CF | CORNING | 50 mL/pk | EUR 117.6 |
Description: Media Catalog; Cell Culture Reagents |
![]() Human Proinsulin (PI) ELISA Kit |
|||
DLR-PI-Hu-48T | DL Develop | 48T | EUR 574.8 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Proinsulin (PI) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
![]() Human Proinsulin (PI) ELISA Kit |
|||
DLR-PI-Hu-96T | DL Develop | 96T | EUR 745.2 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Proinsulin (PI) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
![]() Porcine Proinsulin (PI) ELISA Kit |
|||
DLR-PI-p-48T | DL Develop | 48T | EUR 656.4 |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Porcine Proinsulin (PI) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
![]() Porcine Proinsulin (PI) ELISA Kit |
|||
DLR-PI-p-96T | DL Develop | 96T | EUR 858 |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Porcine Proinsulin (PI) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
![]() Human Proinsulin (PI) ELISA Kit |
|||
RD-PI-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 573.6 |
![]() Human Proinsulin (PI) ELISA Kit |
|||
RD-PI-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 794.4 |
![]() Porcine Proinsulin (PI) ELISA Kit |
|||
RD-PI-p-48Tests | Reddot Biotech | 48 Tests | EUR 666 |
![]() Porcine Proinsulin (PI) ELISA Kit |
|||
RD-PI-p-96Tests | Reddot Biotech | 96 Tests | EUR 925.2 |
![]() Human Proinsulin (PI) ELISA Kit |
|||
RDR-PI-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 600 |
![]() Human Proinsulin (PI) ELISA Kit |
|||
RDR-PI-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 830.4 |
![]() Porcine Proinsulin (PI) ELISA Kit |
|||
RDR-PI-p-48Tests | Reddot Biotech | 48 Tests | EUR 696 |
![]() Porcine Proinsulin (PI) ELISA Kit |
|||
RDR-PI-p-96Tests | Reddot Biotech | 96 Tests | EUR 968.4 |
![]() Amphotericin B (Fungizone) Sol, 250 µg/mL |
|||
CCM1120-100 | Bio Basic | 100 mL | EUR 132.28 |
![]() Fluorguard Antifade Mounting Medium |
|||
F001 | Insitus Biotechnologies | 1 ml | EUR 103.2 |
![]() Latex-in-a-Box Conjugation Kit, Blue 0.3 micron, 7 mL |
|||
LIB03-B007 | BioAssayWorks | 7 mL | EUR 880.73 |
Description: Latex-in-a-Box Conjugation Kit conjugates blue 0.3 micron latex nanoparticles to antibodies and proteins. The nanoparticles are created using a special technology that needs only one hour to conjugate the particles to the antibody/protein. |
![]() Latex-in-a-Box Conjugation Kit, Red 0.3 micron, 7 mL |
|||
LIB03-R007 | BioAssayWorks | 7 mL | EUR 880.73 |
Description: Latex-in-a-Box Conjugation Kit conjugates red 0.3 micron latex nanoparticles to antibodies and proteins. The nanoparticles are created using a special technology that needs only one hour to conjugate the particles to the antibody/protein. |
![]() Penicillin-Streptomycin 100X Solution, 10, 000 Units/mL, 10, 000 µg/mL |
|||
CCM1133-100 | Bio Basic | 100 mL | EUR 76.86 |
![]() Starch Indicator 0.3% |
|||
ST0305 | Scientific Laboratory Supplies | 500ML | EUR 93.48 |
![]() Pi-minimal Screen HTS (1.7 ml per well) |
|||
M-CS-211L | MiTeGen | 96 solutions | EUR 508 |
Description: Pi-minimal Screen HTS (1.7 ml per well) |
![]() Pi-PEG Screen HTS (1.7 ml per well) |
|||
M-CS-212L | MiTeGen | 96 solutions | EUR 508 |
Description: Pi-PEG Screen HTS (1.7 ml per well) |
![]() 100 ML PENICILLIN-STREPTOMYCIN-L-GLUTAMINE, 100X, 10,000 I.U. PENCILLIN (PER ML) 10,000 µG/ML STREPTOMYCIN 29.2 MG/ML L-GLUTAMINE |
|||
30-009-CI | CORNING | 100 mL/pk | EUR 96 |
Description: Media Catalog; Cell Culture Reagents |
![]() PI |
|||
abx290031-400tests | Abbexa | 400 tests | EUR 309.6 |
![]() pI |
|||
EF007077 | Lifescience Market | 96 Tests | EUR 826.8 |
![]() Human Paraoxonase 1 (PON) Standards QQ and RR Phenotypes (2 x 0.3 mL) |
|||
0801384 | Zeptometrix | 2 x 0.3 mL | EUR 396.96 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
![]() PI/ Rat PI ELISA Kit |
|||
ELA-E0379r | Lifescience Market | 96 Tests | EUR 1063.2 |
![]() Brilliant Cresyl Blue (0.3%, Alcoholic) |
|||
BCA3800 | ScyTek Laboratories | 1 Gal. | EUR 289.2 |
![]() Brilliant Cresyl Blue (0.3%, Alcoholic) |
|||
BCA500 | ScyTek Laboratories | 500 ml | EUR 108 |
![]() Brilliant Cresyl Blue (0.3%, Alcoholic) |
|||
BCA999 | ScyTek Laboratories | 1000 ml | EUR 139.2 |
![]() Hydrogen Peroxide 0.3% w/v |
|||
HP035 | Scientific Laboratory Supplies | 5L | EUR 120.84 |
![]() Hydrogen Peroxide 0.3% w/v |
|||
HP03F | Scientific Laboratory Supplies | 1L | EUR 43.32 |
![]() Random Hexamers 100 µg |
|||
26-4000-03 | Gene Link | 100 ug | EUR 150 |
Description: Random Primers are a mixture of oligonucleotides representing all possible sequence for that size. Random Primers can be used to prime synthesis in oligo-labeling similar to using hexamers (1,2) and cDNA synthesis. Random prime labeling yields high specific activity labeled DNA probe which can be used for all southern, northern and in situ hybridization studies. Random Primers can be also used similar to using hexamers in cDNA synthesis in combination with oligo d(T) to yield more 5' end cDNA sequence. Recently random primers have been used to detect DNA polymorphism. These polymorphisms, simply detected as DNA segments which amplify from one parent but not the other, are inherited in a Mendelian fashion and can be used to construct genetic maps in a variety of species. The authors suggested that these polymorphisms be called RAPD (pronounced RAPID) makers, after Random Amplified Polymorphic DNA (3). References 1. Feinberg, A.P. & Vogelstein, B. (1983) Anal. Biochem. 132:6-13. 2. Feinberg, A.P. & Vogelstein, B. (1984) Anal. Biochem. 137:266-267. 3. Williams J. G., Kubelik A.R., Livak K.J., Rafalski J.A. & Tingey S.V. (1990) Nucleic Acid Res. 18(22):6531-5. |
![]() 0.3 ml 8-Strip Tubes & Domed Caps, 250 Strips of 8 Tubes and Caps |
|||
GP209 | GenDepot | 2,000 tubes/caps | EUR 400.8 |
![]() PI-103 |
|||
1728-1 | Biovision | EUR 183.6 |
![]() PI-103 |
|||
1728-5 | Biovision | EUR 502.8 |
![]() PI-103 |
|||
1728-50 | Biovision | Ask for price |
![]() PI-103 |
|||
A2067-100 | ApexBio | 100 mg | EUR 1005.6 |
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1]. |
![]() PI-103 |
|||
A2067-25 | ApexBio | 25 mg | EUR 393.6 |
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1]. |
![]() PI-103 |
|||
A2067-5 | ApexBio | 5 mg | EUR 176.4 |
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1]. |
![]() PI-103 |
|||
A2067-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 184.8 |
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1]. |
![]() PI-103 |
|||
A2067-S | ApexBio | Evaluation Sample | EUR 97.2 |
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1]. |
![]() PI / RNAse |
|||
abx290029-200tests | Abbexa | 200 tests | EUR 326.4 |
![]() PI-3065 |
|||
B4660-10 | ApexBio | 10 mg | EUR 268.8 |
Description: PI-3065 is a small molecule and selective inhibitor of p110?kinase with an Ki value of 1.5nM and IC50 value of 5nM [1].PI-3065 has been reported to selectively inhibit p110?kinase with Ki values of 15nM, 110nM, 130nM and 940nM |
![]() PI-3065 |
|||
B4660-100 | ApexBio | 100 mg | EUR 950.4 |
Description: PI-3065 is a small molecule and selective inhibitor of p110?kinase with an Ki value of 1.5nM and IC50 value of 5nM [1].PI-3065 has been reported to selectively inhibit p110?kinase with Ki values of 15nM, 110nM, 130nM and 940nM |
![]() PI-3065 |
|||
B4660-5 | ApexBio | 5 mg | EUR 199.2 |
Description: PI-3065 is a small molecule and selective inhibitor of p110?kinase with an Ki value of 1.5nM and IC50 value of 5nM [1].PI-3065 has been reported to selectively inhibit p110?kinase with Ki values of 15nM, 110nM, 130nM and 940nM |
![]() PI-3065 |
|||
B4660-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 212.4 |
Description: PI-3065 is a small molecule and selective inhibitor of p110?kinase with an Ki value of 1.5nM and IC50 value of 5nM [1].PI-3065 has been reported to selectively inhibit p110?kinase with Ki values of 15nM, 110nM, 130nM and 940nM |
![]() PI-3065 |
|||
B4660-50 | ApexBio | 50 mg | EUR 686.4 |
Description: PI-3065 is a small molecule and selective inhibitor of p110?kinase with an Ki value of 1.5nM and IC50 value of 5nM [1].PI-3065 has been reported to selectively inhibit p110?kinase with Ki values of 15nM, 110nM, 130nM and 940nM |
![]() PI-1840 |
|||
B4755-10 | ApexBio | 10 mg | EUR 220.8 |
Description: PI-1840 is a potent and selective inhibitor of proteasome with IC50 value of 27 nM for chymotrypsinlike (CT-L) activity [1]. The 26S proteasome consists of a 19S regulatory particle (RP) and a 20S core particle. |
![]() PI-1840 |
|||
B4755-50 | ApexBio | 50 mg | EUR 626.4 |
Description: PI-1840 is a potent and selective inhibitor of proteasome with IC50 value of 27 nM for chymotrypsinlike (CT-L) activity [1]. The 26S proteasome consists of a 19S regulatory particle (RP) and a 20S core particle. |
![]() PI-3065 |
|||
B1674-25 | Biovision | EUR 607.2 |
![]() PI-3065 |
|||
B1674-5 | Biovision | EUR 189.6 |
![]() PI 828 |
|||
B7198-1 | ApexBio | 1 mg | EUR 151.2 |
![]() PI 828 |
|||
B7198-10 | ApexBio | 10 mg | EUR 381.6 |
![]() PI 828 |
|||
B7198-5 | ApexBio | 5 mg | EUR 243.6 |
![]() PI-103 |
|||
E1KS1038 | EnoGene | 5mg | EUR 390 |
![]() PI-103 |
|||
HY-10115 | MedChemExpress | 100mg | EUR 655.2 |
![]() PI-828 |
|||
HY-108606 | MedChemExpress | 1mg | EUR 170.4 |
![]() PI-3065 |
|||
HY-12235 | MedChemExpress | 10mM/1mL | EUR 244.8 |
![]() PI-1840 |
|||
HY-12286 | MedChemExpress | 50mg | EUR 704.4 |
![]() DiagPoly Amine Polystyrene Particles, 0.3 µm |
|||
DNM-F002 | Creative Diagnostics | 10 mL | EUR 696 |
![]() In Situ Plate Seals, 10 seals |
|||
ML-CDSF1-10 | MiTeGen | 10 SEALS | EUR 160 |
Description: In Situ Plate Seals, 10 seals |
![]() Glutathione S-Transferase Pi (GST pi) Antibody |
|||
abx020559-10ug | Abbexa | 10 ug | EUR 410.4 |
![]() Modular In Situ-1 96 Well Crystallization Plate |
|||
ML-MIS-FP3D | MiTeGen | 1 PLATE | EUR 392 |
Description: Modular In Situ-1 96 Well Crystallization Plate |
![]() PI-8 antibody |
|||
70R-12052 | Fitzgerald | 100 ug | EUR 470.4 |
Description: Rabbit polyclonal PI-8 antibody |
![]() PI-8 Antibody |
|||
3748-100 | Biovision | EUR 379.2 |
![]() PI-8 Antibody |
|||
3748-30T | Biovision | EUR 175.2 |
![]() PI Staining Kit |
|||
abx097208-1Kit | Abbexa | 1 Kit | EUR 276 |
![]() PI-103 Hydrochloride |
|||
A3724-100 | ApexBio | 100 mg | EUR 1005.6 |
Description: PI-103 is a dual inhibitor of PI3K/Akt and mTOR with IC50 value of 0.002 ?M , 0.003?M, 0.003?M, 0.015?M, 0.030?M for P110?, P110?, P110?, P110 and mTOR, respectively. |
![]() PI-103 Hydrochloride |
|||
A3724-25 | ApexBio | 25 mg | EUR 393.6 |
Description: PI-103 is a dual inhibitor of PI3K/Akt and mTOR with IC50 value of 0.002 ?M , 0.003?M, 0.003?M, 0.015?M, 0.030?M for P110?, P110?, P110?, P110 and mTOR, respectively. |
![]() PI-103 Hydrochloride |
|||
A3724-5 | ApexBio | 5 mg | EUR 176.4 |
Description: PI-103 is a dual inhibitor of PI3K/Akt and mTOR with IC50 value of 0.002 ?M , 0.003?M, 0.003?M, 0.015?M, 0.030?M for P110?, P110?, P110?, P110 and mTOR, respectively. |
![]() PI-103 Hydrochloride |
|||
A3724-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 184.8 |
Description: PI-103 is a dual inhibitor of PI3K/Akt and mTOR with IC50 value of 0.002 ?M , 0.003?M, 0.003?M, 0.015?M, 0.030?M for P110?, P110?, P110?, P110 and mTOR, respectively. |
![]() Phosphatidylinositol (PI) Antibody |
|||
20-abx179006 | Abbexa |
|
|
![]() Human PI Protein |
|||
20-abx650990 | Abbexa |
|
|
![]() PI-103 (Hydrochloride) |
|||
HY-10115A | MedChemExpress | 5mg | EUR 142.8 |
![]() Pi-Methylimidazoleacetic acid |
|||
HY-113274 | MedChemExpress | 5mg | EUR 224.4 |
![]() Recombinant Proinsulin (PI) |
|||
4-RPA379Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Proinsulin expressed in: E.coli |
![]() GST pi Antibody |
|||
R30668 | NSJ Bioreagents | 100 ug | EUR 419 |
![]() Pi-minimal Screen |
|||
M-CS-127 | MiTeGen | 4 x 24 solutions | EUR 1109 |
Description: Pi-minimal Screen |
![]() Pi-PEG Screen |
|||
M-CS-128 | MiTeGen | 4 x 24 solutions | EUR 1109 |
Description: Pi-PEG Screen |
![]() DiagPoly Plain Polystyrene Particles, 0.2-0.3 µm |
|||
DNM-P003 | Creative Diagnostics | 10 mL | EUR 664.8 |
![]() Anti-Pichia pastoris HCP |
|||
PI-49 | Cygnus Technologies | 1 ml | EUR 400.8 |
Description: Anti-Pichia pastoris HCP by Cygnus Technologies is available in Europe via Gentaur. |
![]() Anti-Pichia pastoris HCP |
|||
PI-49AF | Cygnus Technologies | 1 mg | EUR 2295.6 |
Description: Anti-Pichia pastoris HCP by Cygnus Technologies is available in Europe via Gentaur. |
![]() Anti-Pichia pastoris HCP |
|||
PI-49PA | Cygnus Technologies | 1 ml | EUR 585.6 |
Description: Anti-Pichia pastoris HCP by Cygnus Technologies is available in Europe via Gentaur. |
![]() Anti-PON1 Clone KRJ1 (100 µg) |
|||
0801012 | Zeptometrix | 100 µg | EUR 340.8 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
![]() Anti-PON1 Clone KRJ2 (100 µg) |
|||
0801014 | Zeptometrix | 100 µg | EUR 340.8 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
![]() bFGF-nAb Purified Protein 25 µg |
|||
ABP-NAB-BFGFAB | Allele Biotech | 25 µg | Ask for price |
![]() bFGF-nAb Plus Biotinylated 25 µg |
|||
ABP-NAB-BFGFPB | Allele Biotech | 25 µg | Ask for price |
![]() GFP-nAb Purified Protein 25 µg |
|||
ABP-NAB-GFPAB | Allele Biotech | 25 µg | Ask for price |
![]() GFP-nAb Plus Biotinylated 25 µg |
|||
ABP-NAB-GFPPB | Allele Biotech | 25 µg | Ask for price |
![]() mNeonGreen-nAb Purified Protein 25 µg |
|||
ABP-NAB-MNGAB | Allele Biotech | 25 µg | Ask for price |
![]() mNeonGreen-nAb Plus Biotinylated 25 µg |
|||
ABP-NAB-MNGPB | Allele Biotech | 25 µg | Ask for price |
![]() RFP-nAb Purified Protein 25 µg |
|||
ABP-NAB-RFPAB | Allele Biotech | 25 ug | Ask for price |
![]() RFP-nAb Plus Biotinylated 25 µg |
|||
ABP-NAB-RFPPB | Allele Biotech | 25 µg | Ask for price |
![]() BrightGreen miRNA qPCR MasterMix-Low ROX |
|||
MasterMix-mL | ABM | 4 x 1.25 ml for 500 reactions | EUR 181.2 |
![]() Rat Monoclonal Anti-Mouse CD4 Pur. Low Endotoxin (Clone YTS 191.1) (rat IgG2b) |
|||
MCD004-ML | Alpha Diagnostics | 100 ug | EUR 489.6 |